Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Phytomedicine Plus is Scopus-indexed (Q1, CiteScore 6), DOAJ. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2667-0313Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 10 / 79 | 87th | Q1 |
| Complementary and Alternative Medicine | 18 / 115 | 84th | Q1 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q1, CiteScore 6.
Phytomedicine Plus is Q1 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 10 of 79) and Q1 in Complementary and Alternative Medicine (rank 18 of 115), by CiteScore 2025.
Phytomedicine Plus is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 6, quartile Q1, 87th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.548, quartile Q2, with an H-index of 33.
The publisher lists an article processing charge of about US$1,590 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Phytomedicine Plus is published by Elsevier B.V. Its ISSN is 2667-0313.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Phytomedicine Plus has an h-index of 39 and a 2-year mean of 3.68 citations per paper (OpenAlex). Its Scopus CiteScore is 6, quartile Q1. On 2-year citations it ranks #12 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
Phytomedicine Plus published 225 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2025–2026), authors are most often from India (22%), Thailand (12.7%) and Iran (6.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (1 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.